The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC
Marco Perna(Azienda Ospedaliero-Universitaria Careggi), Alessio Bruni(University of Modena and Reggio Emilia), Filippo Alongi(Ospedale Sacro Cuore Don Calabria), Vieri Scotti(University of Florence), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia), Davide Franceschini(IRCCS Humanitas Research Hospital), Andrea Riccardo Filippi(University of Turin), Domenico Genovesi(Ospedale SS. Annunziata), Maria Taraborrelli(Ospedale SS. Annunziata), Paolo Borghetti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Stefano Vagge(Ospedale Policlinico San Martino), Luca Frassinelli(University of Modena and Reggio Emilia), Elisa D’Angelo(Azienda Ospedaliero-Universitaria di Modena), Lorenzo Livi(European Society for Sexual Medicine), Matteo Mariotti(Azienda Ospedaliero-Universitaria Careggi), Lorenzo Falcinelli, Stefano Maria Magrini(University of Brescia), Federica Bertolini, Niccolò Giaj‐Levra(Ospedale Sacro Cuore Don Calabria), Frank Lohr(University of Modena and Reggio Emilia), A. Taddeo(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Viola Salvestrini(Azienda Ospedaliero-Universitaria Careggi), R Rossi(Azienda Sanitaria Unità Locale di Reggio Emilia), Gianluca Costantino(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Alessandra Fozza(Ospedale Policlinico San Martino), Carlo Greco(Università Campus Bio-Medico)
Cited by 11
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
|Lung Cancer|2009|277
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial
|Annals of Surgical Oncology|2022|162
Stereotactic body radiation therapy for lung metastases
|Lung Cancer|2011|146